You are here

July 19, 2018 is the new effective and compliance date for the revised Common Rule (also known as the "Final Rule")

On January 17, 2018, an interim final rule (IFR), titled Federal Policy for the Protection of Human Subjects: Delay of the Revisions to the Federal Policy for the Protection of Human Subjects, was released. The IFR delays the effective date and general compliance date of the revised Common Rule for six months. All provisions are covered except the cooperative research ("single IRB") provision, whose compliance date remains January 20, 2020.

To help the research ethics and oversight community understand and adapt to this change, please see the one-page guide, Delay of the Revised Common Rule: What Does It Mean For Me? which was developed by PRIM&R (Public Responsibility in Medicine and Research).  Please refer back to this website for updates on UH's implementation of the revised Common Rule.

Summary of major changes

  • Continuing Review: No longer required for some minimal risk research, including studies where the only remaining activity is the analysis of identifiable data/biospecimens or activity to obtain follow-up clinical data.
  • Exemptions - New categories and clarification of existing categories. Some exemptions may require "limited IRB review" (to ensure the protection and confidentiality of data), while others may qualify for "self-determination."
  • Informed Consent - A new "Key Elements" section and a rearrangement of content is designed to facilitate a potential subject's decision to participate or not. Revised UH model consent forms are now posted on the HSP website. These model consent forms must be followed if your study is approved after July 19, 2018 although we encourage their use now.  
  • Single IRB-of-Record (sIRB) - IRB oversight for most federally-funded collaborative research projects located in the U.S. will be required to use a single IRB (commercial, academic, or hospital-based) starting January 20, 2020. See below for information about the NIH sIRB policy implementation, as well as other recent NIH policies related to clinical trials.

What to Expect

The new regulations do not impact studies approved prior to July 19, 2018. For new studies, expect to see:

  1. IRB application changes
  2. Revisions to the Informed Consent templates
  3. Human Research Protection Program (HRPP) General Policy Manual updates
  4. UH IRB standard operating procedure (SOP) updates
  5. A conservative approach as to when UH will be the sIRB, with IRB consultation recommended prior to application submission

For existing studies, the UH IRBs may choose to apply the new rules to minimize burden for investigators.

UH Actions

The UH Human Studies Program (HSP) and the 3 UH IRBs are working to collectively interpret the new Common Rule elements and update the University’s policies, business processes, and eProtocol system to accommodate the changes while maintaining a high level of subject protection. A Final Rule working group was established to propose needed changes.

Decisions made so far

  • Informed Consent - Revised UH model consent forms are now posted on the HSP website. These model consent forms must be followed if your study is approved after July 19, 2018 although we encourage their use now.  
  • Exemptions - At this time, UH will not implement the new regulatory “Broad Consent” option as for the informed consent process because of the additional tracking requirement required for participants who choose to “opt-out” of providing broad consent. Since this is required for Exemption categories 7 and 8, these new exempt categories will not be implemented.
  • Single IRB-of-Record (sIRB) - UH will continue to assess its criteria for whether UH will serve as the single IRB-of-Record or cede review to another institution or a commercial IRB. UH is now participating in a pilot program to track IRB review agreements between institutions. Contact the HSP Office for information on using this system, called SmartIRB. Please contact Victoria Rivera for more information about SmartIRB.